RA Medical Systems (NYSE:RMED) and Invivo Therapeutics (NASDAQ:NVIV) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for RA Medical Systems and Invivo Therapeutics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RA Medical Systems 0 3 1 0 2.25
Invivo Therapeutics 0 0 0 0 N/A

RA Medical Systems presently has a consensus target price of $1.50, indicating a potential upside of 189.18%. Given RA Medical Systems’ higher probable upside, analysts plainly believe RA Medical Systems is more favorable than Invivo Therapeutics.

Insider and Institutional Ownership

14.4% of RA Medical Systems shares are owned by institutional investors. Comparatively, 2.8% of Invivo Therapeutics shares are owned by institutional investors. 25.2% of RA Medical Systems shares are owned by insiders. Comparatively, 0.6% of Invivo Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

RA Medical Systems has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Invivo Therapeutics has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500.

Valuation and Earnings

This table compares RA Medical Systems and Invivo Therapeutics’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
RA Medical Systems $7.20 million 1.00 -$56.96 million ($4.33) -0.12
Invivo Therapeutics N/A N/A -$11.83 million N/A N/A

Invivo Therapeutics has lower revenue, but higher earnings than RA Medical Systems.


This table compares RA Medical Systems and Invivo Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
RA Medical Systems -732.37% -130.46% -101.56%
Invivo Therapeutics N/A -138.75% -99.84%


RA Medical Systems beats Invivo Therapeutics on 6 of the 10 factors compared between the two stocks.

RA Medical Systems Company Profile

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

Invivo Therapeutics Company Profile

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. has research collaboration with the Q Therapeutics, Inc. for the evaluation of the combination of PLGA-PLL based Neuro-Spinal Scaffold with adult neural progenitor cells, including those from induced pluripotent stem cells. The company was founded in 2005 and is headquartered in Cambridge, Massachusetts.

Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.